mirror of
https://github.com/soapingtime/diyhrt.git
synced 2026-09-03 11:30:18 +02:00
[automated] update diyhrt.market
This commit is contained in:
@@ -421,12 +421,12 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels
|
||||
<a
|
||||
href="../products/cyproterone-procur-50mg-x50.html"
|
||||
class="list-group-item list-group-item-action px-2 px-sm-3 py-1"
|
||||
style="border-left-width: 0.2rem; border-left-color: #18B2CB; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
|
||||
style="border-left-width: 0.2rem; border-left-color: #31D4FF; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
|
||||
<div class="row">
|
||||
<div class="col-7 col-sm-4 d-flex align-items-center">
|
||||
<span>
|
||||
Cyproterone (Procur) 50mg<br />
|
||||
<span style="color: #18B2CB;">United Pharmacies UK</span>
|
||||
<span style="color: #31D4FF;">4NRX Pharmacy UK</span>
|
||||
</span>
|
||||
</div>
|
||||
|
||||
@@ -468,12 +468,12 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels
|
||||
<a
|
||||
href="../products/cyproterone-procur-50mg-x50.html"
|
||||
class="list-group-item list-group-item-action px-2 px-sm-3 py-1"
|
||||
style="border-left-width: 0.2rem; border-left-color: #31D4FF; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
|
||||
style="border-left-width: 0.2rem; border-left-color: #18B2CB; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
|
||||
<div class="row">
|
||||
<div class="col-7 col-sm-4 d-flex align-items-center">
|
||||
<span>
|
||||
Cyproterone (Procur) 50mg<br />
|
||||
<span style="color: #31D4FF;">4NRX Pharmacy UK</span>
|
||||
<span style="color: #18B2CB;">United Pharmacies UK</span>
|
||||
</span>
|
||||
</div>
|
||||
|
||||
@@ -677,7 +677,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels
|
||||
|
||||
|
||||
|
||||
25 days ago
|
||||
6 days ago
|
||||
|
||||
|
||||
|
||||
@@ -724,7 +724,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels
|
||||
|
||||
|
||||
|
||||
210 days ago
|
||||
217 days ago
|
||||
|
||||
|
||||
|
||||
@@ -746,7 +746,7 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels
|
||||
<a
|
||||
href="../products/cyproterone-siterone-100mg-x50.html"
|
||||
class="list-group-item list-group-item-action px-2 px-sm-3 py-1"
|
||||
style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-success);">
|
||||
style="border-left-width: 0.2rem; border-left-color: #EC008B; border-right-width: 0.2rem; border-right-color: var(--bs-danger);">
|
||||
<div class="row">
|
||||
<div class="col-7 col-sm-4 d-flex align-items-center">
|
||||
<span>
|
||||
@@ -774,9 +774,15 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels
|
||||
<div class="col-12 col-sm d-flex justify-content-end text-end align-items-center">
|
||||
|
||||
|
||||
<span class="text-success">
|
||||
<span class="text-danger">
|
||||
|
||||
In Stock
|
||||
|
||||
|
||||
|
||||
8 days ago
|
||||
|
||||
|
||||
|
||||
|
||||
</span>
|
||||
|
||||
@@ -831,5 +837,5 @@ Cyproterone has a statistically associated risk of Meningiomas, prolactin levels
|
||||
const tooltipTriggerList = document.querySelectorAll('[data-bs-toggle="tooltip"]')
|
||||
const tooltipList = [...tooltipTriggerList].map(tooltipTriggerEl => new bootstrap.Tooltip(tooltipTriggerEl))
|
||||
</script>
|
||||
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'99fb87802b95d6a5',t:'MTc2MzM0MzcyMw=='};var a=document.createElement('script');a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body>
|
||||
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'9a353d047f8e524b',t:'MTc2Mzk0ODg0Ng=='};var a=document.createElement('script');a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body>
|
||||
</html>
|
||||
|
||||
Reference in New Issue
Block a user